{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:07:15Z","timestamp":1791216435010,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ejca.2014.02.016","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T17:01:38Z","timestamp":1394643698000},"page":"1291-1300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer"],"prefix":"10.1016","volume":"50","author":[{"given":"Patrick","family":"Weller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Bankfalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Dominas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6tz F.","family":"Lehnerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Zeidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Brandau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A.","family":"Dumitru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2014.02.016_b0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.pathol.4.110807.092158","article-title":"Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment","volume":"4","author":"Pai","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ejca.2014.02.016_b0010","unstructured":"Ries Lagy JL, Eisner MP, Lin YD, Horner MJ, editors. Cancer survival among adults: U.S. SEER program, 1988\u20132001. Patient and tumor characteristics. National Cancer Institute, SEER Program; 2007."},{"key":"10.1016\/j.ejca.2014.02.016_b0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ejca.2004.10.031","article-title":"Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach","volume":"41","author":"Almadori","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2014.02.016_b0020","first-page":"8","article-title":"Cancer statistics, 2004","volume":"54","author":"Jemal","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2014.02.016_b0025","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/gcc.10062","article-title":"Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression","volume":"34","author":"Huang","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ejca.2014.02.016_b0030","first-page":"32","article-title":"Expanding role of the medical oncologist in the management of head and neck cancer","volume":"58","author":"Choong","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2014.02.016_b0035","first-page":"43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2014.02.016_b0040","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ijc.20740","article-title":"Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database","volume":"114","author":"Carvalho","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2014.02.016_b0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2006.05.042","article-title":"FOXP3 controls regulatory T cell function through cooperation with NFAT","volume":"126","author":"Wu","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2014.02.016_b0050","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.4049\/jimmunol.180.8.5163","article-title":"Cutting edge: broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells","volume":"180","author":"Chen","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ejca.2014.02.016_b0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1479-5876-6-19","article-title":"Foxp3 expression in human cancer cells","volume":"6","author":"Karanikas","year":"2008","journal-title":"J Transl Med"},{"key":"10.1016\/j.ejca.2014.02.016_b0060","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/jcp.24125","article-title":"FOXP3 expression in tumor cells and implications for cancer progression","volume":"228","author":"Triulzi","year":"2013","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejca.2014.02.016_b0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-010-0831-1","article-title":"Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy","volume":"125","author":"Ladoire","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2014.02.016_b0070","first-page":"1677","article-title":"Association of FOXP3 expression with non-small cell lung cancer","volume":"31","author":"Dimitrakopoulos","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2014.02.016_b0075","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1755-148X.2011.00879.x","article-title":"FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy","volume":"24","author":"Quaglino","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.ejca.2014.02.016_b0080","first-page":"3545","article-title":"Correlation between elevated FOXP3 expression and increased lymph node metastasis of gastric cancer","volume":"123","author":"Wang","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ejca.2014.02.016_b0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1442-2050.2009.01013.x","article-title":"Expression of FOXP3 in esophageal squamous cell carcinoma relating to the clinical data","volume":"23","author":"Xue","year":"2010","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.ejca.2014.02.016_b0090","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1464-410X.2010.10020.x","article-title":"FOXP3 and survival in urinary bladder cancer","volume":"108","author":"Winerdal","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.ejca.2014.02.016_b0095","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.oraloncology.2011.04.017","article-title":"Foxp3 expressed by tongue squamous cell carcinoma cells correlates with clinicopathologic features and overall survival in tongue squamous cell carcinoma patients","volume":"47","author":"Liang","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ejca.2014.02.016_b0100","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1368-8375(03)00105-2","article-title":"Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor","volume":"39","author":"Itoh","year":"2003","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ejca.2014.02.016_b0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1158\/1078-0432.CCR-07-2028","article-title":"Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer","volume":"14","author":"Sackett","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2014.02.016_b0110","doi-asserted-by":"crossref","first-page":"e56420","DOI":"10.1371\/journal.pone.0056420","article-title":"AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma","volume":"8","author":"Dumitru","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2014.02.016_b0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fimmu.2013.00033","article-title":"Neutrophils activate tumoral CORTACTIN to enhance progression of orohypopharynx carcinoma","volume":"4","author":"Dumitru","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejca.2014.02.016_b0120","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/sj.bjc.6604245","article-title":"Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status","volume":"98","author":"Hofman","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2014.02.016_b0125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hed.21856","article-title":"Significance of molecular markers in survival prediction of oral squamous cell carcinoma","volume":"34","author":"Kim","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.ejca.2014.02.016_b0130","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/cm.20296","article-title":"Cortactin branches out: roles in regulating protrusive actin dynamics","volume":"65","author":"Ammer","year":"2008","journal-title":"Cell Motil Cytoskeleton"},{"key":"10.1016\/j.ejca.2014.02.016_b0135","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1158\/0008-5472.CAN-09-4439","article-title":"Pseudopodial actin dynamics control epithelial\u2013mesenchymal transition in metastatic cancer cells","volume":"70","author":"Shankar","year":"2010","journal-title":"Cancer Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914001786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914001786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:21:03Z","timestamp":1760732463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804914001786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0959804914001786"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2014.02.016","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2014.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}